Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
Rationale ( R,S )-ketamine, an N -methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of ( R,S )-ketami...
Saved in:
Published in: | Psychopharmacology Vol. 235; no. 11; pp. 3177 - 3185 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01-11-2018
Springer Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Rationale
(
R,S
)-ketamine, an
N
-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (
R,S
)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (
R,S
)-ketamine, the deuterium isotope effects in the antidepressant actions of (
R
)-ketamine, which is more potent than (
S
)-ketamine, are unknown.
Methods
We examined whether deuterium substitution at the C6 position could affect antidepressant effects of (
R
)-ketamine in a chronic social defeat stress (CSDS) model.
Results
Pharmacokinetic studies showed that levels of (2
R
,6
R
)-d
1
-hydroxynorketamine [(2
R
,6
R
)-d
1
-HNK], a final metabolite of (
R
)-d
2
-ketamine, in the plasma and brain after administration of (
R
)-d
2
-ketamine (10 mg/kg) were lower than those of (2
R
,6
R
)-HNK from (
R
)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2
R
,6
R
)-HNK. In contrast, levels of (
R
)-ketamine and its metabolite (
R
)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (
R
)-ketamine (10 mg/kg) and (
R
)-d
2
-ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (
R
)-ketamine.
Conclusions
The present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (
R
)-ketamine to (2
R
,6
R
)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (
R
)-ketamine in a CSDS model. Therefore, it is unlikely that (2
R
,6
R
)-HNK is essential for antidepressant effects of (
R
)-ketamine. |
---|---|
AbstractList | Rationale (R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (R,S)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (R,S)-ketamine, the deuterium isotope effects in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown. Methods We examined whether deuterium substitution at the C6 position could affect antidepressant effects of (R)-ketamine in a chronic social defeat stress (CSDS) model. Results Pharmacokinetic studies showed that levels of (2R,6R)-d.sub.1-hydroxynorketamine [(2R,6R)-d.sub.1-HNK], a final metabolite of (R)-d.sub.2-ketamine, in the plasma and brain after administration of (R)-d.sub.2-ketamine (10 mg/kg) were lower than those of (2R,6R)-HNK from (R)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2R,6R)-HNK. In contrast, levels of (R)-ketamine and its metabolite (R)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (R)-ketamine (10 mg/kg) and (R)-d.sub.2-ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (R)-ketamine. Conclusions The present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (R)-ketamine to (2R,6R)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (R)-ketamine in a CSDS model. Therefore, it is unlikely that (2R,6R)-HNK is essential for antidepressant effects of (R)-ketamine. (R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (R,S)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (R,S)-ketamine, the deuterium isotope effects in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown. We examined whether deuterium substitution at the C6 position could affect antidepressant effects of (R)-ketamine in a chronic social defeat stress (CSDS) model. Pharmacokinetic studies showed that levels of (2R,6R)-d -hydroxynorketamine [(2R,6R)-d -HNK], a final metabolite of (R)-d -ketamine, in the plasma and brain after administration of (R)-d -ketamine (10 mg/kg) were lower than those of (2R,6R)-HNK from (R)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2R,6R)-HNK. In contrast, levels of (R)-ketamine and its metabolite (R)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (R)-ketamine (10 mg/kg) and (R)-d -ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (R)-ketamine. The present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (R)-ketamine to (2R,6R)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (R)-ketamine in a CSDS model. Therefore, it is unlikely that (2R,6R)-HNK is essential for antidepressant effects of (R)-ketamine. (R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (R,S)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (R,S)-ketamine, the deuterium isotope effects in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown. We examined whether deuterium substitution at the C6 position could affect antidepressant effects of (R)-ketamine in a chronic social defeat stress (CSDS) model. Pharmacokinetic studies showed that levels of (2R,6R)-d.sub.1-hydroxynorketamine [(2R,6R)-d.sub.1-HNK], a final metabolite of (R)-d.sub.2-ketamine, in the plasma and brain after administration of (R)-d.sub.2-ketamine (10 mg/kg) were lower than those of (2R,6R)-HNK from (R)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2R,6R)-HNK. In contrast, levels of (R)-ketamine and its metabolite (R)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (R)-ketamine (10 mg/kg) and (R)-d.sub.2-ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (R)-ketamine. The present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (R)-ketamine to (2R,6R)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (R)-ketamine in a CSDS model. Therefore, it is unlikely that (2R,6R)-HNK is essential for antidepressant effects of (R)-ketamine. Rationale(R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (R,S)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (R,S)-ketamine, the deuterium isotope effects in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown.MethodsWe examined whether deuterium substitution at the C6 position could affect antidepressant effects of (R)-ketamine in a chronic social defeat stress (CSDS) model.ResultsPharmacokinetic studies showed that levels of (2R,6R)-d1-hydroxynorketamine [(2R,6R)-d1-HNK], a final metabolite of (R)-d2-ketamine, in the plasma and brain after administration of (R)-d2-ketamine (10 mg/kg) were lower than those of (2R,6R)-HNK from (R)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2R,6R)-HNK. In contrast, levels of (R)-ketamine and its metabolite (R)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (R)-ketamine (10 mg/kg) and (R)-d2-ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (R)-ketamine.ConclusionsThe present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (R)-ketamine to (2R,6R)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (R)-ketamine in a CSDS model. Therefore, it is unlikely that (2R,6R)-HNK is essential for antidepressant effects of (R)-ketamine. RATIONALE(R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (R,S)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (R,S)-ketamine, the deuterium isotope effects in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown.METHODSWe examined whether deuterium substitution at the C6 position could affect antidepressant effects of (R)-ketamine in a chronic social defeat stress (CSDS) model.RESULTSPharmacokinetic studies showed that levels of (2R,6R)-d1-hydroxynorketamine [(2R,6R)-d1-HNK], a final metabolite of (R)-d2-ketamine, in the plasma and brain after administration of (R)-d2-ketamine (10 mg/kg) were lower than those of (2R,6R)-HNK from (R)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2R,6R)-HNK. In contrast, levels of (R)-ketamine and its metabolite (R)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (R)-ketamine (10 mg/kg) and (R)-d2-ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (R)-ketamine.CONCLUSIONSThe present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (R)-ketamine to (2R,6R)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (R)-ketamine in a CSDS model. Therefore, it is unlikely that (2R,6R)-HNK is essential for antidepressant effects of (R)-ketamine. Rationale ( R,S )-ketamine, an N -methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of ( R,S )-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of ( R,S )-ketamine, the deuterium isotope effects in the antidepressant actions of ( R )-ketamine, which is more potent than ( S )-ketamine, are unknown. Methods We examined whether deuterium substitution at the C6 position could affect antidepressant effects of ( R )-ketamine in a chronic social defeat stress (CSDS) model. Results Pharmacokinetic studies showed that levels of (2 R ,6 R )-d 1 -hydroxynorketamine [(2 R ,6 R )-d 1 -HNK], a final metabolite of ( R )-d 2 -ketamine, in the plasma and brain after administration of ( R )-d 2 -ketamine (10 mg/kg) were lower than those of (2 R ,6 R )-HNK from ( R )-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2 R ,6 R )-HNK. In contrast, levels of ( R )-ketamine and its metabolite ( R )-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both ( R )-ketamine (10 mg/kg) and ( R )-d 2 -ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of ( R )-ketamine. Conclusions The present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from ( R )-ketamine to (2 R ,6 R )-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of ( R )-ketamine in a CSDS model. Therefore, it is unlikely that (2 R ,6 R )-HNK is essential for antidepressant effects of ( R )-ketamine. |
Audience | Academic |
Author | Yamaguchi, Jun-ichi Mizuno-Yasuhira, Akiko Chaki, Shigeyuki Fujita, Yuko Chang, Lijia Hashimoto, Kenji Ma, Min Harada, Shingo Qu, Youge Zhang, Kai Toki, Hidetoh Nemoto, Tetsuhiro |
Author_xml | – sequence: 1 givenname: Kai surname: Zhang fullname: Zhang, Kai organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Wuxi Mental Health Center, Nanjing Medical University – sequence: 2 givenname: Hidetoh surname: Toki fullname: Toki, Hidetoh organization: Research Headquarters, Taisho Pharmaceutical Co., Ltd – sequence: 3 givenname: Yuko surname: Fujita fullname: Fujita, Yuko organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health – sequence: 4 givenname: Min surname: Ma fullname: Ma, Min organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health – sequence: 5 givenname: Lijia surname: Chang fullname: Chang, Lijia organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health – sequence: 6 givenname: Youge surname: Qu fullname: Qu, Youge organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health – sequence: 7 givenname: Shingo surname: Harada fullname: Harada, Shingo organization: Graduate School of Pharmaceutical Sciences, Chiba University – sequence: 8 givenname: Tetsuhiro surname: Nemoto fullname: Nemoto, Tetsuhiro organization: Graduate School of Pharmaceutical Sciences, Chiba University – sequence: 9 givenname: Akiko surname: Mizuno-Yasuhira fullname: Mizuno-Yasuhira, Akiko organization: Research Headquarters, Taisho Pharmaceutical Co., Ltd – sequence: 10 givenname: Jun-ichi surname: Yamaguchi fullname: Yamaguchi, Jun-ichi organization: Research Headquarters, Taisho Pharmaceutical Co., Ltd – sequence: 11 givenname: Shigeyuki surname: Chaki fullname: Chaki, Shigeyuki organization: Research Headquarters, Taisho Pharmaceutical Co., Ltd – sequence: 12 givenname: Kenji surname: Hashimoto fullname: Hashimoto, Kenji email: hashimoto@faculty.chiba-u.jp organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30215218$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kV1rFDEUhoNU7Lb6A7yRgDf1YtqTr5nZy1LaKiwIUq9DNnPSpp1J1iSD-O-bYWuLognk6zzvS5L3iByEGJCQ9wxOGUB3lgE4Ew2wvlHAuoa_IismBW84dPyArACEaART_SE5yvkeapO9fEMORdUpzvoV-bkx9oFGRwecCyY_T9TnWOIOKTqHtmTqAy13SE0ofsBdwpzr8rlapSffPjUPWMzkAy60ofYuxeAtzdF6M1Zvh6bQXBYxneKA41vy2pkx47un-Zh8v7q8ufjcbL5ef7k43zRWgSqNBLFds84Z3llhXTt0fFAGbC95KzvAbmtlrRscWiGWvZEK-2HNAHupehDH5GTvu0vxx4y56Mlni-NoAsY5a85AQSvXal3Rj3-h93FOod5uoYRol-GFujUjah9cLMnYxVSfq7Z-sOI9q9TpP6jaB5y8rSk6X8__ELC9wKaYc0Knd8lPJv3SDPQStt6HrWvYeglb86r58HTheTvh8Kz4nW4F-B7ItRRuMb286P-uj4s6s1w |
CitedBy_id | crossref_primary_10_3389_fphar_2024_1337749 crossref_primary_10_1080_14737175_2019_1643237 crossref_primary_10_1016_j_ejphar_2023_176032 crossref_primary_10_1016_j_pbb_2019_04_008 crossref_primary_10_1016_j_neuropharm_2022_109305 crossref_primary_10_1016_j_neuropharm_2022_109348 crossref_primary_10_3390_molecules25184173 crossref_primary_10_1016_j_neuropharm_2022_109378 crossref_primary_10_1177_1179069518815445 crossref_primary_10_3390_molecules25010023 crossref_primary_10_1016_j_bcp_2020_113935 crossref_primary_10_1038_s41380_019_0400_x crossref_primary_10_1124_pharmrev_120_000149 crossref_primary_10_1016_j_jpba_2022_115168 crossref_primary_10_1111_pcn_12902 crossref_primary_10_1016_j_pbb_2020_172870 crossref_primary_10_1016_j_pbb_2020_172876 crossref_primary_10_1038_s41380_021_01121_1 crossref_primary_10_1007_s00406_024_01809_9 crossref_primary_10_1111_bph_14683 crossref_primary_10_1016_j_bbr_2019_111904 crossref_primary_10_1038_s41398_019_0624_1 crossref_primary_10_1016_j_bbr_2020_112631 crossref_primary_10_1038_s41598_020_61983_3 crossref_primary_10_1080_14737175_2019_1554434 |
Cites_doi | 10.1016/j.biopsych.2017.05.016 10.1016/j.biopsych.2012.03.004 10.1176/appi.ajp.2013.13030392 10.1124/jpet.116.239228 10.1001/jamapsychiatry.2017.0080 10.1176/appi.ajp.2017.17020239 10.1001/archpsyc.63.8.856 10.1016/j.coph.2014.11.005 10.1007/s00406-016-0718-1 10.1016/j.biopsych.2017.01.002 10.1016/j.biopsych.2013.03.026 10.1038/s41386-018-0084-y 10.1038/mp.2017.255 10.1093/ijnp/pyx120 10.2174/1570159X15666170221101054 10.1124/pr.117.015198 10.1080/14728222.2016.1238899 10.1038/nm.4050 10.1038/s41598-018-22449-9 10.1007/s00406-016-0692-7 10.1021/cr50004a004 10.1016/j.drudis.2018.02.006 10.1093/ijnp/pyy053 10.1093/ijnp/pyx108 10.1016/j.psychres.2016.03.034 10.1016/0883-2897(86)90256-4 10.1016/j.jpba.2017.09.033 10.1038/nature17998 10.3109/00498254.2012.685777 10.1176/appi.ajp.2017.17040472 10.1016/j.pbb.2018.07.003 10.1017/S0033291716000064 10.1016/S0006-3223(99)00230-9 10.1001/archgenpsychiatry.2010.90 10.1016/S2215-0366(17)30102-5 10.1093/ijnp/pyx100 10.1038/s41398-017-0031-4 10.1017/S0033291716000969 10.1176/appi.ajp.2015.15040465 10.1016/j.pbb.2013.11.033 10.1093/ijnp/pyv124 10.1016/j.biopsych.2016.12.020 10.1038/tp.2015.136 10.1016/j.conb.2014.12.004 10.1016/0165-6147(84)90534-0 10.1016/S2215-0366(17)30272-9 10.1176/appi.ajp.2016.16040411 10.1016/j.biopsych.2017.12.007 10.1124/dmd.30.7.853 10.1093/ijnp/pyy065 |
ContentType | Journal Article |
Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2018 COPYRIGHT 2018 Springer Psychopharmacology is a copyright of Springer, (2018). All Rights Reserved. |
Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2018 – notice: COPYRIGHT 2018 Springer – notice: Psychopharmacology is a copyright of Springer, (2018). All Rights Reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1007/s00213-018-5017-2 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Proquest Nursing & Allied Health Source Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Chemoreception Abstracts ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Psychology MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 3185 |
ExternalDocumentID | A560045281 10_1007_s00213_018_5017_2 30215218 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development grantid: JP18dm0107119 funderid: http://dx.doi.org/10.13039/100009619 – fundername: Japan Agency for Medical Research and Development grantid: JP18dm0107119 |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS KOW N2Q R9- RHV SBY SOJ X7M ~EX --- -56 -5G -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 123 199 1N0 1SB 2.D 203 28- 29P 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2QV 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 96X AAAVM AABHQ AACDK AAEOY AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQLM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABSXP ABTAH ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIPQ ACIWK ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. B0M BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 DWQXO DXH EAD EAP EBC EBD EBLON EBS ECM EIF EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPAXT EPL EPS ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICJ IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M2M M4Y MA- MK0 N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF- PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TN5 TSG TSK TSV TUC TUS U2A U9L UAP UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WIP WJK WK6 WK8 WOW XOL YLTOR YQJ YYP Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZY4 ~8M AAYXX CITATION 7QG 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c505t-403b917fa27c3cf6d72d5a0c8426470e7bc4917aed63370e7a45e8d910e845803 |
IEDL.DBID | AEJHL |
ISSN | 0033-3158 |
IngestDate | Fri Oct 25 22:07:13 EDT 2024 Thu Oct 10 16:49:31 EDT 2024 Tue Nov 19 21:21:30 EST 2024 Tue Nov 12 23:31:57 EST 2024 Fri Aug 23 01:56:17 EDT 2024 Wed Oct 16 00:50:45 EDT 2024 Wed Oct 12 10:50:01 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | 2 Deuterium isotope effect ketamine 6 ( hydroxynorketamine Metabolism (2R,6R)-hydroxynorketamine (R)-ketamine |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c505t-403b917fa27c3cf6d72d5a0c8426470e7bc4917aed63370e7a45e8d910e845803 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 30215218 |
PQID | 2103361033 |
PQPubID | 47309 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2105064959 proquest_journals_2103361033 gale_infotracmisc_A560045281 gale_infotracacademiconefile_A560045281 crossref_primary_10_1007_s00213_018_5017_2 pubmed_primary_30215218 springer_journals_10_1007_s00213_018_5017_2 |
PublicationCentury | 2000 |
PublicationDate | 2018-11-01 |
PublicationDateYYYYMMDD | 2018-11-01 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacology |
PublicationTitleAbbrev | Psychopharmacology |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2018 |
Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
References | Hashimoto, Kakiuchi, Ohba, Nishiyama, Tsukada (CR17) 2017; 267 CR35 Hashimoto (CR14) 2016; 173 Sanacora, Frye, McDonald, Mathew, Turner, Schatzberg, Summergrad, Nemeroff (CR25) 2017; 74 Yang, Ren, Qu, Zhang, Ma, Dong, Hashimoto (CR42) 2018; 83 Hashimoto (CR12) 2016; 46 Wilkinson, Ballard, Bloch, Mathew, Murrough, Feder, Sos, Wang, Zarate, Sanacora (CR34) 2018; 175 Chaki (CR3) 2017; 15 Shirayama, Hashimoto (CR26) 2017; 267 Wiberg (CR32) 1955; 55 Xu, Hackett, Carter, Loo, Gálvez, Glozier, Glue, Lapidus, McGirr, Somogyi, Mitchell, Rodgers (CR36) 2016; 19 Chaki (CR4) 2018; 21 Hashimoto, Shirayama (CR15) 2018; 84 Zarate, Singh, Carlson, Brutsche, Ameli, Luckenbaugh, Charney, Manji (CR46) 2006; 63 Hashimoto (CR13) 2016; 20 Berman, Cappiello, Anand, Oren, Heninger, Charney, Krystal (CR2) 2000; 47 Zhang, Li, Hashimoto (CR48) 2014; 116 Yang, Shirayama, Zhang, Ren, Yao, Ma, Dong, Hashimoto (CR38) 2015; 5 Foster (CR9) 1984; 5 Wilkinson, Toprak, Turner, Levine, Katz, Sanacora (CR33) 2017; 174 Desta, Moaddel, Ogburn, Xu, Ramamoorthy, Venkata, Sanghvi, Goldberg, Torjman, Wainer (CR6) 2012; 42 Shirayama, Hashimoto (CR27) 2018; 21 Zanos, Moaddel, Morris, Georgiou, Fischell, Elmer, Alkondon, Yuan, Pribut, Singh, Dossou, Fang, Huang, Mayo, Wainer, Albuquerque, Thompson, Thomas, Zarate, Gould (CR44) 2016; 533 Zhang, Fujita, Hashimoto (CR50) 2018; 8 Fukumoto, Toki, Iijima, Hashihayata, Yamaguchi, Hashimoto, Chaki (CR10) 2017; 361 Kavalali, Monteggia (CR19) 2015; 20 Diazgranados, Ibrahim, Brutsche, Newberg, Kronstein, Khalife, Kammerer, Quezado, Luckenbaugh, Salvadore, Machado-Vieira, Manji, Zarate (CR7) 2010; 67 Zhang, Dong, Fujita, Fujita, Hashimoto (CR49) 2018; 21 Newport, Carpenter, WM, Potash, Tohen, Nemeroff (CR24) 2015; 172 CR51 Chang, Toki, Qu, Fujita, Mizuno-Yasuhira, Yamaguchi, Chaki, Hashimoto (CR5) 2018; 21 Hashimoto, Inoue, Suzuki, Yamasaki, Kojima (CR16) 1986; 13 Zanos, Gould (CR43) 2018; 23 Zanos, Moaddel, Morris, Riggs, Highland, Georgiou, Pereira, Albuquerque, Thomas, Zarate, Gould (CR45) 2018; 70 Short, Fong, Galvez, Shelker, Loo (CR28) 2018; 5 Yamaguchi, Toki, Qu, Yang, Koike, Hashimoto, Mizuno-Yasuhira, Chaki (CR37) 2018; 43 Duman, Aghajanian, Sanacora, Krystal (CR8) 2016; 22 Yang, Qu, Abe, Nozawa, Chaki, Hashimoto (CR40) 2017; 82 Abdallah (CR1) 2017; 81 Kishimoto, Chawla, Hagi, Zarate, Kane, Bauer, Correll (CR20) 2016; 46 Singh, Morgan, Curran, Nutt, Schlag, McShane (CR29) 2017; 4 Tian, Dong, Fujita, Fujita, Hashimoto (CR30) 2018; 172 Monteggia, Zarate (CR22) 2015; 30 Yang, Han, Zhang, Ren, Hashimoto (CR39) 2016; 239 Yang, Qu, Fujita, Ren, Ma, Dong, Hashimoto (CR41) 2017; 7 Hijazi, Boulieu (CR18) 2002; 30 Krystal, Sanacora, Duman (CR21) 2013; 73 Murrough, Iosifescu, Chang, Al Jurdi, Green, Perez, Iqbal, Pillemer, Foulkes, Shah, Charney, Mathew (CR23) 2013; 170 Garay, Zarate, Cavero, Kim, Charpeaud, Skolnick (CR11) 2018; 23 Zarate, Brutsche, Ibrahim, Franco-Chaves, Diazgranados, Cravchik, Selter, Marquardt, Liberty, Luckenbaugh (CR47) 2012; 72 Toki, Ichikawa, Mizuno-Yasuhara, Yamaguchi (CR31) 2018; 148 JW Murrough (5017_CR23) 2013; 170 Ricardo Garay (5017_CR11) 2018; 23 Lijia Chang (5017_CR5) 2018; 21 K Hashimoto (5017_CR16) 1986; 13 C Yang (5017_CR40) 2017; 82 K Hashimoto (5017_CR14) 2016; 173 5017_CR35 K Zhang (5017_CR49) 2018; 21 N Diazgranados (5017_CR7) 2010; 67 J Yamaguchi (5017_CR37) 2018; 43 H Toki (5017_CR31) 2018; 148 LM Monteggia (5017_CR22) 2015; 30 Y Xu (5017_CR36) 2016; 19 CA Zarate Jr (5017_CR47) 2012; 72 B Short (5017_CR28) 2018; 5 Y Shirayama (5017_CR26) 2017; 267 CG Abdallah (5017_CR1) 2017; 81 RM Berman (5017_CR2) 2000; 47 DJ Newport (5017_CR24) 2015; 172 C Yang (5017_CR42) 2018; 83 S Chaki (5017_CR3) 2017; 15 K Fukumoto (5017_CR10) 2017; 361 T Kishimoto (5017_CR20) 2016; 46 K Zhang (5017_CR50) 2018; 8 K Hashimoto (5017_CR12) 2016; 46 AB Foster (5017_CR9) 1984; 5 ST Wilkinson (5017_CR33) 2017; 174 Z Tian (5017_CR30) 2018; 172 RS Duman (5017_CR8) 2016; 22 ET Kavalali (5017_CR19) 2015; 20 JH Krystal (5017_CR21) 2013; 73 K Hashimoto (5017_CR15) 2018; 84 Y Shirayama (5017_CR27) 2018; 21 P Zanos (5017_CR43) 2018; 23 KB Wiberg (5017_CR32) 1955; 55 I Singh (5017_CR29) 2017; 4 C Yang (5017_CR38) 2015; 5 C Yang (5017_CR39) 2016; 239 P Zanos (5017_CR44) 2016; 533 Z Desta (5017_CR6) 2012; 42 Y Hijazi (5017_CR18) 2002; 30 K Hashimoto (5017_CR17) 2017; 267 5017_CR51 K Hashimoto (5017_CR13) 2016; 20 CA Zarate Jr (5017_CR46) 2006; 63 S Chaki (5017_CR4) 2018; 21 P Zanos (5017_CR45) 2018; 70 ST Wilkinson (5017_CR34) 2018; 175 JC Zhang (5017_CR48) 2014; 116 G Sanacora (5017_CR25) 2017; 74 C Yang (5017_CR41) 2017; 7 |
References_xml | – volume: 83 start-page: 18 year: 2018 end-page: 28 ident: CR42 article-title: Mechanistic target of rapamycin-independent antidepressant effects of ( )-ketamine in a social defeat stress model publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2017.05.016 contributor: fullname: Hashimoto – volume: 72 start-page: 331 year: 2012 end-page: 338 ident: CR47 article-title: Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2012.03.004 contributor: fullname: Luckenbaugh – volume: 170 start-page: 1134 year: 2013 end-page: 1142 ident: CR23 article-title: Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2013.13030392 contributor: fullname: Mathew – volume: 361 start-page: 9 year: 2017 end-page: 16 ident: CR10 article-title: Antidepressant potential of ( )-ketamine in rodent models: comparison with ( )-ketamine publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.116.239228 contributor: fullname: Chaki – ident: CR51 – volume: 74 start-page: 399 year: 2017 end-page: 405 ident: CR25 article-title: A consensus statement on the use of ketamine in the treatment of mood disorders publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2017.0080 contributor: fullname: Nemeroff – volume: 174 start-page: 695 year: 2017 end-page: 696 ident: CR33 article-title: A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2017.17020239 contributor: fullname: Sanacora – volume: 63 start-page: 856 year: 2006 end-page: 864 ident: CR46 article-title: A randomized trial of an -methyl-D-aspartate antagonist in treatment-resistant major depression publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.8.856 contributor: fullname: Manji – volume: 20 start-page: 35 year: 2015 end-page: 39 ident: CR19 article-title: How does ketamine elicit a rapid antidepressant response? publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2014.11.005 contributor: fullname: Monteggia – ident: CR35 – volume: 267 start-page: 177 year: 2017 end-page: 182 ident: CR26 article-title: Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-016-0718-1 contributor: fullname: Hashimoto – volume: 81 start-page: e61 year: 2017 end-page: e63 ident: CR1 article-title: What’s the buzz about hydroxynorketamine? Is it the history, the story, the debate, or the promise? publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2017.01.002 contributor: fullname: Abdallah – volume: 73 start-page: 1133 year: 2013 end-page: 1141 ident: CR21 article-title: Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2013.03.026 contributor: fullname: Duman – volume: 43 start-page: 1900 year: 2018 end-page: 1907 ident: CR37 article-title: (2 ,6 )-Hydroxynorketamine is not essential for the antidepressant actions of ( )-ketamine in mice publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0084-y contributor: fullname: Chaki – volume: 23 start-page: 801 year: 2018 end-page: 811 ident: CR43 article-title: Mechanisms of ketamine action as an antidepressant publication-title: Mol Psychiatry doi: 10.1038/mp.2017.255 contributor: fullname: Gould – volume: 21 start-page: 154 year: 2018 end-page: 156 ident: CR4 article-title: Is metabolism of ( )-ketamine essential for the antidepressant effects? publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyx120 contributor: fullname: Chaki – volume: 15 start-page: 963 year: 2017 end-page: 976 ident: CR3 article-title: Beyond ketamine: new approaches to the development of safer antidepressants publication-title: Curr Neuropharmacol doi: 10.2174/1570159X15666170221101054 contributor: fullname: Chaki – volume: 70 start-page: 621 year: 2018 end-page: 660 ident: CR45 article-title: Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms publication-title: Pharmacol Rev doi: 10.1124/pr.117.015198 contributor: fullname: Gould – volume: 20 start-page: 1389 year: 2016 end-page: 1392 ident: CR13 article-title: Ketamine’s antidepressant action: beyond NMDA receptor inhibition publication-title: Expert Opin Ther Targets doi: 10.1080/14728222.2016.1238899 contributor: fullname: Hashimoto – volume: 22 start-page: 238 year: 2016 end-page: 249 ident: CR8 article-title: Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants publication-title: Nat Med doi: 10.1038/nm.4050 contributor: fullname: Krystal – volume: 8 start-page: 4007 year: 2018 ident: CR50 article-title: Lack of metabolism in ( )-ketamine’s antidepressant actions in a chronic social defeat stress model publication-title: Sci Rep doi: 10.1038/s41598-018-22449-9 contributor: fullname: Hashimoto – volume: 267 start-page: 173 year: 2017 end-page: 176 ident: CR17 article-title: Reduction of dopamine D receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-016-0692-7 contributor: fullname: Tsukada – volume: 55 start-page: 713 year: 1955 end-page: 743 ident: CR32 article-title: The deuterium isotope effect publication-title: Chem Rev doi: 10.1021/cr50004a004 contributor: fullname: Wiberg – volume: 23 start-page: 1689 issue: 10 year: 2018 end-page: 1692 ident: CR11 article-title: The development of glutamate-based antidepressants is taking longer than expected publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2018.02.006 contributor: fullname: Skolnick – volume: 21 start-page: 932 issue: 10 year: 2018 end-page: 937 ident: CR5 article-title: No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model publication-title: International Journal of Neuropsychopharmacology doi: 10.1093/ijnp/pyy053 contributor: fullname: Hashimoto – volume: 21 start-page: 84 year: 2018 end-page: 88 ident: CR27 article-title: Lack of antidepressant effects of (2 ,6 )-hydroxynorketamine in a rat learned helplessness model: comparison with ( )-ketamine publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyx108 contributor: fullname: Hashimoto – volume: 239 start-page: 281 year: 2016 end-page: 283 ident: CR39 article-title: Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine publication-title: Psychiatry Res doi: 10.1016/j.psychres.2016.03.034 contributor: fullname: Hashimoto – volume: 13 start-page: 79 year: 1986 end-page: 80 ident: CR16 article-title: Deuterium isotope effect of [ C]N,N-dimethylphenethylamine-α,α-d : reduction in metabolic trapping rate in brain publication-title: Int J Rad Appl Instrum B doi: 10.1016/0883-2897(86)90256-4 contributor: fullname: Kojima – volume: 148 start-page: 288 year: 2018 end-page: 297 ident: CR31 article-title: A rapid and sensitive chiral LC-MS/MS method for the determination of ketamine and norketamine in mouse plasma, brain and cerebrospinal fluid applicable to the stereoselective pharmacokinetic study of ketamine publication-title: J Pharm Biomed Anal doi: 10.1016/j.jpba.2017.09.033 contributor: fullname: Yamaguchi – volume: 533 start-page: 481 year: 2016 end-page: 486 ident: CR44 article-title: NMDAR inhibition-independent antidepressant actions of ketamine metabolites publication-title: Nature doi: 10.1038/nature17998 contributor: fullname: Gould – volume: 42 start-page: 1076 year: 2012 end-page: 1087 ident: CR6 article-title: Stereoselective and regiospecific hydroxylation of ketamine and norketamine publication-title: Xenobiotica doi: 10.3109/00498254.2012.685777 contributor: fullname: Wainer – volume: 175 start-page: 150 year: 2018 end-page: 158 ident: CR34 article-title: The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2017.17040472 contributor: fullname: Sanacora – volume: 172 start-page: 17 year: 2018 end-page: 21 ident: CR30 article-title: Expression of heat shock protein HSP-70 in the rerosplenial cortex of rat brain after administration of ( )-ketamine and ( )-ketamine, but not ( )-ketamine publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2018.07.003 contributor: fullname: Hashimoto – volume: 46 start-page: 1459 year: 2016 end-page: 1472 ident: CR20 article-title: Single-dose infusion ketamine and non-ketamine -methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories publication-title: Psychol Med doi: 10.1017/S0033291716000064 contributor: fullname: Correll – volume: 47 start-page: 351 year: 2000 end-page: 354 ident: CR2 article-title: Antidepressant effects of ketamine in depressed patients publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(99)00230-9 contributor: fullname: Krystal – volume: 67 start-page: 793 year: 2010 end-page: 802 ident: CR7 article-title: A randomized add-on trial of an -methyl-D-aspartate antagonist in treatment-resistant bipolar depression publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.90 contributor: fullname: Zarate – volume: 4 start-page: 419 year: 2017 end-page: 426 ident: CR29 article-title: Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30102-5 contributor: fullname: McShane – volume: 21 start-page: 157 year: 2018 end-page: 163 ident: CR49 article-title: 5-Hydroxytryptamine-independent antidepressant actions of ( )-ketamine in a chronic social defeat stress model publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyx100 contributor: fullname: Hashimoto – volume: 7 start-page: 1294 year: 2017 ident: CR41 article-title: Possible role of the gut microbiota-brain axis in the antidepressant effects of ( )-ketamine sin a social defeat stress model publication-title: Transl Psychiatry doi: 10.1038/s41398-017-0031-4 contributor: fullname: Hashimoto – volume: 46 start-page: 2449 year: 2016 end-page: 2451 ident: CR12 article-title: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity publication-title: Psychol Med doi: 10.1017/S0033291716000969 contributor: fullname: Hashimoto – volume: 172 start-page: 950 year: 2015 end-page: 966 ident: CR24 article-title: Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2015.15040465 contributor: fullname: Nemeroff – volume: 116 start-page: 137 year: 2014 end-page: 141 ident: CR48 article-title: R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2013.11.033 contributor: fullname: Hashimoto – volume: 19 year: 2016 ident: CR36 article-title: Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyv124 contributor: fullname: Rodgers – volume: 82 start-page: e43 year: 2017 end-page: e44 ident: CR40 article-title: ( )-ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2 ,6 )-hydroxynorketamine publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2016.12.020 contributor: fullname: Hashimoto – volume: 5 start-page: e632 year: 2015 ident: CR38 article-title: R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects publication-title: Transl Psychiatry doi: 10.1038/tp.2015.136 contributor: fullname: Hashimoto – volume: 30 start-page: 139 year: 2015 end-page: 143 ident: CR22 article-title: Antidepressant actions of ketamine: from molecular mechanisms to clinical practice publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2014.12.004 contributor: fullname: Zarate – volume: 5 start-page: 524 year: 1984 end-page: 527 ident: CR9 article-title: Deuterium isotope effects in studies of drug metabolism publication-title: Trends Pharmacol Sci doi: 10.1016/0165-6147(84)90534-0 contributor: fullname: Foster – volume: 5 start-page: 65 year: 2018 end-page: 78 ident: CR28 article-title: Side-effects associated with ketamine use in depression: a systematic review publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30272-9 contributor: fullname: Loo – volume: 173 start-page: 1044 year: 2016 end-page: 1045 ident: CR14 article-title: Detrimental side effects of repeated ketamine infusions in the brain publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2016.16040411 contributor: fullname: Hashimoto – volume: 84 start-page: e7 year: 2018 end-page: e8 ident: CR15 article-title: What are the causes for discrepancies of antidepressant actions of (2 ,6 )-hydroxynorketamine? publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2017.12.007 contributor: fullname: Shirayama – volume: 30 start-page: 853 year: 2002 end-page: 858 ident: CR18 article-title: Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to -demethylation of ketamine in human liver microsomes publication-title: Drug Metab Dispos doi: 10.1124/dmd.30.7.853 contributor: fullname: Boulieu – volume: 20 start-page: 1389 year: 2016 ident: 5017_CR13 publication-title: Expert Opin Ther Targets doi: 10.1080/14728222.2016.1238899 contributor: fullname: K Hashimoto – volume: 170 start-page: 1134 year: 2013 ident: 5017_CR23 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2013.13030392 contributor: fullname: JW Murrough – volume: 172 start-page: 950 year: 2015 ident: 5017_CR24 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2015.15040465 contributor: fullname: DJ Newport – volume: 148 start-page: 288 year: 2018 ident: 5017_CR31 publication-title: J Pharm Biomed Anal doi: 10.1016/j.jpba.2017.09.033 contributor: fullname: H Toki – volume: 55 start-page: 713 year: 1955 ident: 5017_CR32 publication-title: Chem Rev doi: 10.1021/cr50004a004 contributor: fullname: KB Wiberg – volume: 46 start-page: 2449 year: 2016 ident: 5017_CR12 publication-title: Psychol Med doi: 10.1017/S0033291716000969 contributor: fullname: K Hashimoto – volume: 70 start-page: 621 year: 2018 ident: 5017_CR45 publication-title: Pharmacol Rev doi: 10.1124/pr.117.015198 contributor: fullname: P Zanos – volume: 73 start-page: 1133 year: 2013 ident: 5017_CR21 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2013.03.026 contributor: fullname: JH Krystal – volume: 174 start-page: 695 year: 2017 ident: 5017_CR33 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2017.17020239 contributor: fullname: ST Wilkinson – ident: 5017_CR35 – ident: 5017_CR51 doi: 10.1093/ijnp/pyy065 – volume: 239 start-page: 281 year: 2016 ident: 5017_CR39 publication-title: Psychiatry Res doi: 10.1016/j.psychres.2016.03.034 contributor: fullname: C Yang – volume: 175 start-page: 150 year: 2018 ident: 5017_CR34 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2017.17040472 contributor: fullname: ST Wilkinson – volume: 13 start-page: 79 year: 1986 ident: 5017_CR16 publication-title: Int J Rad Appl Instrum B doi: 10.1016/0883-2897(86)90256-4 contributor: fullname: K Hashimoto – volume: 15 start-page: 963 year: 2017 ident: 5017_CR3 publication-title: Curr Neuropharmacol doi: 10.2174/1570159X15666170221101054 contributor: fullname: S Chaki – volume: 4 start-page: 419 year: 2017 ident: 5017_CR29 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30102-5 contributor: fullname: I Singh – volume: 5 start-page: 524 year: 1984 ident: 5017_CR9 publication-title: Trends Pharmacol Sci doi: 10.1016/0165-6147(84)90534-0 contributor: fullname: AB Foster – volume: 5 start-page: 65 year: 2018 ident: 5017_CR28 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30272-9 contributor: fullname: B Short – volume: 74 start-page: 399 year: 2017 ident: 5017_CR25 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2017.0080 contributor: fullname: G Sanacora – volume: 46 start-page: 1459 year: 2016 ident: 5017_CR20 publication-title: Psychol Med doi: 10.1017/S0033291716000064 contributor: fullname: T Kishimoto – volume: 22 start-page: 238 year: 2016 ident: 5017_CR8 publication-title: Nat Med doi: 10.1038/nm.4050 contributor: fullname: RS Duman – volume: 72 start-page: 331 year: 2012 ident: 5017_CR47 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2012.03.004 contributor: fullname: CA Zarate Jr – volume: 81 start-page: e61 year: 2017 ident: 5017_CR1 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2017.01.002 contributor: fullname: CG Abdallah – volume: 21 start-page: 157 year: 2018 ident: 5017_CR49 publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyx100 contributor: fullname: K Zhang – volume: 30 start-page: 853 year: 2002 ident: 5017_CR18 publication-title: Drug Metab Dispos doi: 10.1124/dmd.30.7.853 contributor: fullname: Y Hijazi – volume: 83 start-page: 18 year: 2018 ident: 5017_CR42 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2017.05.016 contributor: fullname: C Yang – volume: 267 start-page: 173 year: 2017 ident: 5017_CR17 publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-016-0692-7 contributor: fullname: K Hashimoto – volume: 21 start-page: 154 year: 2018 ident: 5017_CR4 publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyx120 contributor: fullname: S Chaki – volume: 116 start-page: 137 year: 2014 ident: 5017_CR48 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2013.11.033 contributor: fullname: JC Zhang – volume: 82 start-page: e43 year: 2017 ident: 5017_CR40 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2016.12.020 contributor: fullname: C Yang – volume: 23 start-page: 801 year: 2018 ident: 5017_CR43 publication-title: Mol Psychiatry doi: 10.1038/mp.2017.255 contributor: fullname: P Zanos – volume: 84 start-page: e7 year: 2018 ident: 5017_CR15 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2017.12.007 contributor: fullname: K Hashimoto – volume: 361 start-page: 9 year: 2017 ident: 5017_CR10 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.116.239228 contributor: fullname: K Fukumoto – volume: 43 start-page: 1900 year: 2018 ident: 5017_CR37 publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0084-y contributor: fullname: J Yamaguchi – volume: 173 start-page: 1044 year: 2016 ident: 5017_CR14 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2016.16040411 contributor: fullname: K Hashimoto – volume: 21 start-page: 932 issue: 10 year: 2018 ident: 5017_CR5 publication-title: International Journal of Neuropsychopharmacology doi: 10.1093/ijnp/pyy053 contributor: fullname: Lijia Chang – volume: 30 start-page: 139 year: 2015 ident: 5017_CR22 publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2014.12.004 contributor: fullname: LM Monteggia – volume: 267 start-page: 177 year: 2017 ident: 5017_CR26 publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-016-0718-1 contributor: fullname: Y Shirayama – volume: 20 start-page: 35 year: 2015 ident: 5017_CR19 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2014.11.005 contributor: fullname: ET Kavalali – volume: 8 start-page: 4007 year: 2018 ident: 5017_CR50 publication-title: Sci Rep doi: 10.1038/s41598-018-22449-9 contributor: fullname: K Zhang – volume: 172 start-page: 17 year: 2018 ident: 5017_CR30 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2018.07.003 contributor: fullname: Z Tian – volume: 63 start-page: 856 year: 2006 ident: 5017_CR46 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.8.856 contributor: fullname: CA Zarate Jr – volume: 42 start-page: 1076 year: 2012 ident: 5017_CR6 publication-title: Xenobiotica doi: 10.3109/00498254.2012.685777 contributor: fullname: Z Desta – volume: 23 start-page: 1689 issue: 10 year: 2018 ident: 5017_CR11 publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2018.02.006 contributor: fullname: Ricardo Garay – volume: 21 start-page: 84 year: 2018 ident: 5017_CR27 publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyx108 contributor: fullname: Y Shirayama – volume: 67 start-page: 793 year: 2010 ident: 5017_CR7 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.90 contributor: fullname: N Diazgranados – volume: 7 start-page: 1294 year: 2017 ident: 5017_CR41 publication-title: Transl Psychiatry doi: 10.1038/s41398-017-0031-4 contributor: fullname: C Yang – volume: 5 start-page: e632 year: 2015 ident: 5017_CR38 publication-title: Transl Psychiatry doi: 10.1038/tp.2015.136 contributor: fullname: C Yang – volume: 47 start-page: 351 year: 2000 ident: 5017_CR2 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(99)00230-9 contributor: fullname: RM Berman – volume: 19 year: 2016 ident: 5017_CR36 publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyv124 contributor: fullname: Y Xu – volume: 533 start-page: 481 year: 2016 ident: 5017_CR44 publication-title: Nature doi: 10.1038/nature17998 contributor: fullname: P Zanos |
SSID | ssj0000484 ssj0068394 |
Score | 2.4666812 |
Snippet | Rationale
(
R,S
)-ketamine, an
N
-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal... (R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in... Rationale (R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal... Rationale(R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation... RATIONALE(R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation... |
SourceID | proquest gale crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 3177 |
SubjectTerms | Analysis Animals Antidepressants Antidepressive Agents - administration & dosage Antidepressive Agents - chemistry Antidepressive Agents - metabolism Antidepressive Agents - pharmacology Biomedical and Life Sciences Biomedicine Brain Brain - drug effects Brain - metabolism Care and treatment Chronic Disease Depression (Mood disorder) Depression - drug therapy Depression - metabolism Depression - psychology Deuterium Deuterium - administration & dosage Deuterium - chemistry Deuterium - metabolism Disease Models, Animal Dosage and administration Glutamic acid receptors Isotope effect Isotopes Ketamine Ketamine - administration & dosage Ketamine - analogs & derivatives Ketamine - chemistry Ketamine - metabolism Male Mental depression Metabolism Mice Mice, Inbred C57BL N-Methyl-D-aspartic acid receptors Neurosciences Original Investigation Pharmacology/Toxicology Psychiatry Social interactions Stress, Psychological - drug therapy Stress, Psychological - metabolism Stress, Psychological - psychology Treatment Outcome |
Title | Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model |
URI | https://link.springer.com/article/10.1007/s00213-018-5017-2 https://www.ncbi.nlm.nih.gov/pubmed/30215218 https://www.proquest.com/docview/2103361033 https://search.proquest.com/docview/2105064959 |
Volume | 235 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8NkBAv-2CwhbHJSBPjo5mCnTTOY7UVVYhNiIHEm-U6tlRVJIimQvz3u4uTdEXjYXuJEvkrts93Z9_dzwCfLdeOzENhnoo0jLWMwkxEJtQ8cyiejIxqZ8zRr_Tnjfw-JJgc3h1dFNOvrUWyZtRdrBtJI3L9kWFCnBXZ7hqKngRpe20wPBudL_hvTKGX_qOP8t8DMQsKI0tka9j8W41Loukpg_5DQj0xmdaS6PTV__ThNbxs9E428ITyBl7YYhPWfzSW9U3Yv_AY1o89drUIyZr12D67WKBbP76Fh3Ntpqx0LLd0G8Rkfssms7Iq7yxrfEPYpGCoVjKcs0njaIuvXSoWPbg8DKe20rfYNOXWzHiMXuaP8LFuhzKC-UAWVt_WswXXp8Orb6Owub0hNKhVVbgxFWPcCzrNUyOM6-cpzxMdGUk6WBrZdGxiTNc27wtB3zpOrMxRfbEyTmQktmG1KAv7HphFLQvVNEfMiRACxy53lrsxbeayyEQBHLUTp-48SIfq4JjrMVc45orGXPEAvtDUKlrA1b02uolDwKYICksNSAeMEy5PAthdyokLzywnt8ShmoU_U7iDFqJPjwD2umQqSc5shS3ndR6CCcySLIB3nqi63xb1RcMnMoDjloQWlT_bp51_yv0BNjjRYB1RuQur1f3cfoSVWT7_1Kyl3zw6Eqc |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED7BJsFeYAwYgQ2MhAYbi5TF-eE8VrDSiW6aoEh7s1zHlqppybSmQvvvubOTlE7wAC9RIjtOYp_vPufuPgO8M7Gy5B4Ky5znYaJEFBY80qGKC4vmSYvIBWOOvudnF-LzMdHk8C4XxkW7dy5Jp6n7ZDcyRxT7I8KUVCvq3fWkyBIU5fXByeTLcKmAE8q99BcZAgDPxMwpjywVnWfzTy2u2Ka7Gvo3E3XHZ-pM0fDxf33EJjxqkScbeFF5AvdMtQUPTlvf-hbsnXsW69tDNlkmZc0P2R47X_Jb3z6Fn2OlL1ltWWloP4jZ4orN5nVTXxvWRoewWcUQWDIctVkbaounfSne-uHbfnhpGnWFj6baimnP0sv8T3xs26KVYD6Vhbn9ep7Bj-Hx5NMobPdvCDXiqgaXpnyKq0Gr4lxzbbMyj8tURVoQCssjk091guXKlBnndK2S1IgSAYwRSSoi_hzWqroyL4AZxFkI1CypJ-IInNrSmthOaTlXRDoK4KAbOXntaTpkT8js-lxin0vqcxkH8J7GVtIUbm6UVm0mAj6KyLDkgFBgksbiKICdlZo49fRqcScdsp36c4lraM4zOgTwti-mOymcrTL1wtUhosAiLQLY9lLVvzZ3Ww0fiQA-diK0bPyv3_Tyn2q_gYejyelYjk_Ovr6CjZjk0eVX7sBac7Mwu3B_Xi5etxPrF7ucFpc |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED-2Fspe9tF9eWs7DUb3VVPXsmP5qYQ1IduyErYW9iYUfUAotUPjMPrf786ynaZsD2MvIUayHEunu9_l7n4CeGNj5Sg8FJqMZ2GiRBTmPNKhinOH5kmLqE7GHP3ITn-KkwHR5By3tTB1tnsbkvQ1DcTSVFSHc-MOu8I3Mk2UByTClNQs6uDNBB0ZFPTN_uDLaLxSxgnVYfqLHoIBz8rMqaYsFW2U808jrtmp29r6hrm6FT-tzdLwwX-_0EO43yBS1vci9Aju2GIbtr41Mfdt2J94duvrA3a2KtZaHLB9NlnxXl8_hl9jpS9Y6ZixdE7EbHnJZouyKueWNVkjbFYwBJwMV3PWpODi164Vb333_X14YSt1iY-m3oppz97L_J_7OLZD68F8iQurz_F5AufDwdmnUdic6xBqxFsVuqx8il6iU3GmuXY9k8UmVZEWhM6yyGZTnWC7sqbHOV2rJLXCILCxIklFxJ_CRlEW9jkwi_gLAZwjtUXcgVNnnI3dlNy8PNJRAB_aVZRzT98hO6Lmes4lzrmkOZdxAG9pnSVt7epKadVUKOCjiCRL9gkdJmksjgLYWeuJW1KvN7eSIhuVsJDoW3Peo48AXnfNdCeluRW2XNZ9iEAwT_MAnnkJ6342r48gPhIBfGzFaTX4X9_pxT_1fgVbk5OhHH8-_foS7sUkjnXZ5Q5sVFdLuwt3F2a51-yx38kUH1o |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lack+of+deuterium+isotope+effects+in+the+antidepressant+effects+of+%28R%29-ketamine+in+a+chronic+social+defeat+stress+model&rft.jtitle=Psychopharmacology&rft.au=Zhang%2C+Kai&rft.au=Toki%2C+Hidetoh&rft.au=Fujita%2C+Yuko&rft.au=Ma%2C+Min&rft.date=2018-11-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=235&rft.issue=11&rft.spage=3177&rft.epage=3185&rft_id=info:doi/10.1007%2Fs00213-018-5017-2&rft.externalDocID=10_1007_s00213_018_5017_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |